JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4176
PRA Group
PRAA
$731M
| $387K | ﹤0.01% |
14,126
+705
| +5% | +$19.9K |
2013 Q2
24 quarters
|
|
|
BGG
4177
DELISTED
Briggs & Stratton Corp.
BGG
| $385K | ﹤0.01% |
38,769
-386
| -1% | -$4.35K |
2013 Q2
24 quarters
|
|
|
TAST
4178
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $384K | ﹤0.01% |
43,388
-1,291
| -3% | -$11.9K |
2017 Q4
6 quarters
|
|
4179
Vanguard Materials ETF
VAW
$2.87B
| $383K | ﹤0.01% |
3,018
+1,302
| +76% | +$162K |
2015 Q4
14 quarters
|
|
|
BSCN
4180
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
| $383K | ﹤0.01% |
18,112
| – | – |
2018 Q1
5 quarters
|
|
|
BBT
4181
Beacon Financial Corp
BBT
$2.36B
| $382K | ﹤0.01% |
12,738
-14,260
| -53% | -$426K |
2013 Q2
24 quarters
|
|
4182
Goldgroup Mining
GORO
$549M
| $382K | ﹤0.01% |
28,663
-19,564
| -41% | -$265K |
2016 Q4
10 quarters
|
|
4183
Saratoga Investment
SAR
$267M
| $381K | ﹤0.01% |
15,633
-6,065
| -28% | -$148K |
2017 Q4
6 quarters
|
|
|
INFI
4184
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $381K | ﹤0.01% |
219,055
-209,534
| -49% | -$337K |
2018 Q4
2 quarters
|
|
|
GEN
4185
DELISTED
Genesis Healthcare, Inc.
GEN
| $381K | ﹤0.01% |
319,893
-10,076
| -3% | -$12.8K |
2016 Q4
10 quarters
|
|
|
PVLA
4186
Palvella Therapeutics
PVLA
$1.9B
| $379K | ﹤0.01% |
1,069
+731
| +216% | +$218K |
2017 Q3
7 quarters
|
|
4187
J. Jill
JILL
$366M
| $377K | ﹤0.01% |
34,906
+32,227
| +1,203% | +$614K |
2017 Q4
6 quarters
|
|
|
CARB
4188
DELISTED
Carbonite Inc
CARB
| $377K | ﹤0.01% |
14,601
+3,638
| +33% | +$88.8K |
2013 Q4
22 quarters
|
|
4189
Timberland Bancorp
TSBK
$351M
| $376K | ﹤0.01% |
14,146
+1,138
| +9% | +$31.4K |
2016 Q4
10 quarters
|
|
4190
Corcept Therapeutics
CORT
$13.2B
| $375K | ﹤0.01% |
33,641
-122,033
| -78% | -$1.36M |
2016 Q4
10 quarters
|
|
|
EUMV
4191
DELISTED
iShares Edge MSCI Min Vol Europe ETF
EUMV
| $375K | ﹤0.01% |
14,748
-4,292
| -23% | -$108K |
2016 Q2
12 quarters
|
|
4192
Asure Software
ASUR
$228M
| $374K | ﹤0.01% |
49,156
-3,988
| -8% | -$27.5K |
2018 Q2
4 quarters
|
|
4193
United States Natural Gas Fund
UNG
$476M
| $372K | ﹤0.01% |
4,674
+29
| +0.6% | +$2.52K |
2013 Q2
24 quarters
|
|
|
VCRA
4194
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $371K | ﹤0.01% |
11,767
+2,087
| +22% | +$66.6K |
2017 Q4
6 quarters
|
|
4195
Airgain
AIRG
$55M
| $370K | ﹤0.01% |
26,332
-14,153
| -35% | -$204K |
2017 Q4
6 quarters
|
|
4196
John Hancock Multifactor Mid Cap ETF
JHMM
$5.99B
| $370K | ﹤0.01% |
10,224
+181
| +2% | +$6.49K |
2017 Q1
9 quarters
|
|
4197
Lee Enterprises
LEE
$158M
| $369K | ﹤0.01% |
16,485
+5,470
| +50% | +$150K |
2013 Q2
24 quarters
|
|
|
CORV
4198
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $369K | ﹤0.01% |
164,155
+7
| +0% | +$18 |
2015 Q4
14 quarters
|
|
4199
NovaGold Resources
NG
$2.9B
| $367K | ﹤0.01% |
63,580
+47,378
| +292% | +$202K |
2016 Q3
11 quarters
|
|
4200
WisdomTree US Total Dividend Fund
DTD
$1.64B
| $365K | ﹤0.01% |
7,576
| – | – |
2018 Q2
4 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.